XM does not provide services to residents of the United States of America.

Indian shares slide on profit booking ahead of US elections, Fed rate decision



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares slide on profit booking ahead of US elections, Fed rate decision</title></head><body>

Updates at 10:14 a.m IST

By Bharath Rajeswaran

Nov 4 (Reuters) -Indian shares dropped more than 1% on Monday, weighed down by broad-based profit booking, while volatility spiked ahead of the U.S. presidential election and the likelihood of further U.S. interest rate cuts.

The NSE Nifty 50 .NSEI fell 1.4%to 23,964.6 points as of 10:26 a.m. IST, while the BSE Sensex .BSESN lost 1.32% to 78,679.45. They rose about 0.4% each in the special one-hour session during the holiday on Friday.

"Despite the gains on the special session on Friday, the market remains under pressure," said Palka Arora Chopra, director at Master Capital Services.

"Investors are adopting 'selling on any rise' approach, with the market likely to be guided by U.S. presidential elections on Tuesday and rate decisions from several global central banks, including the Fed (Federal Reserve) later in the week."

All the 13 major sectors logged losses.

Analysts said there could be further profit booking in the coming sessions, with volatility likely to rise further, as investors await clarity on the political front and the rate trajectory in the world's largest economy.

The marketsexpect the Fed to opt for a 25 basis point rate cut on Nov. 7. Lower interest rates in the U.S. could spur higher foreign inflows into emerging markets like India.

The Nifty volatility index .NIFVIX rose to 17.25, its highest since early August on Monday.

Drug maker Sun Pharma SUN.NS fell 3% after a U.S. district court granted a preliminary injunction moved by Incyte Corp INCY.O, preventing it from launching a key drug.

Two-wheeler maker Bajaj Auto BAJA.NS fell 4.7% after posting a drop in monthly domestic sales in October.



Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sumana Nandy

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.